From: Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?
Antipsychotic chosen | Physician's choice for patient | Physician's choice if they developed psychosis |
---|---|---|
Atypical | 546 (94%) | 530 (93%) |
Typical | 35 (6%) | 40 (7%) |
No antipsychotic | 4 (0.7%) | 0 |
Olanzapine | 167 (210) | 39.9% 100 (120), 26.2% |
Risperidone | 154 (202) | 36.8% 123 (141), 32.3% |
Haloperidol | 28 (33) | 6.7% 21 (23), 5.5% |
Aripiprazole | 25 (33) | 6% 65 (73) 17% |
Amisulpiride | 17 (21) | 4.1% 19 (24) 5% |
Quetiapine | 22 (36) | 5.3% 25 (37) 6.6% |
Clozapine | 6 (8) | 1.4% 22 (24) 5.8% |
No response given regarding generic drug | 202 | 304 |
Electroconvulsive therapy (ECT) | 0 | 1 0.3% |
Ziprasidone | 0 | 4 1% |
Sertindole | 0 | 1 0.3% |